|
|
|
 |
| |
| Carcinogenesis,
Teratogenesis & Mutagenesis
The forth Editorial Board
|
|
Li
En-min |
|
|
|
Professor
Li En-min, born in August 1963，is now the director
at the Department of Biochemistry and Molecular
Biology, Medical college of Shantou University.
He is also the mentor for postgraduate, doctoral
and post-doctoral students. He has been assigned
the title of Excellent Young Professor of Guangdong
Province since 2004. In addition, He holds many
social positions, such as the members of Marine
Biochemistry and Molecular Biology Society of
China and Association For Biochemistry and Molecular
Biology of Guangdong Province.
He acquired the doctoral degree of Medical Biochemistry
from Bethune Medical University and underwent
postdoctoral research in key laboratory of Genetic
Engineering，University of Agriculture and Animal
Sciences of PLA. In the recent five years, his
main research field focuses on the molecular
biology of esophageal carcinoma and the development
of marine anti-tumor agents. Up to now, a solid
technology platform has been established in
his laboratory, including gene chip, suppression
subtractive hybridization(SSH), two dimensional
gel electrophoresis(2DE), biological mass spectrometry,
luciferase reporter assay system, RNA interference
(RNAi) technology, yeast one-hybrid/two hybrid
system, antibody preparation based on soluble
antigen expressed from cDNA, flow cytometry
(FCM), confocal laser scanning microscopy and
in vivo experiment with nude mice, etc.
In these years, He has undertaken three General
Programs and one International Cooperation and
Communication Program from National Natural
Science Foundation of China(NNSF), and one Key
Program and two General Programs from Guangdong
Provincial Natural Science Foundation as principal
investigator. Meanwhile he has been a major
participant in one Key Program and two General
Program from NNSF. During the five years led
by Prof. Li, the staff has published 58 articles,
29 of them are in SCI-scoped journals.
|
|
| |
|
|
|
| |
 |
| |
 |
| Cheng
Shujun is currently as a professor of Cancer
Institute (Hospital), Chinese Academy of Medical Sciences
& Peking Union Medical College, Beijing, China,
and Chief Scientist of both China State Key Basic
Research Project “Fundamental investigation of human
carcinogenesis and cancer therapy and prevention”
and Beijing key Cancer Research Project “Tumor biomarker
profiling and human cancer diagnosis and therapy”.
He worked as a visiting scientist in Laboratoire de
Medicine Experimental, Institute de la Recherches
Scientifiques sur le Cancer, France (1978-1981), and
in Department of Pathology, Medical College of Ohio,
USA (1986-1987). He has established a series of short-term
tests for the detection of environmental carcinogens
and anti-carcinogens in China. He was elected as a
Member, Chinese Academy of Engineering in 1999. Dr.
Cheng is the President of Chinese Environmental Mutagen
Society, and Vice President of China Anticancer Association.
He found that the tea catechins showed a significant
inhibitory effect against human genital condylomas
and inflammatory hyperplasia. Based on the invention,
he and his collaborators had received international
patents “Composition for treating condyloma acuminate”
in 1998. This invention had been approved to go for
clinical phase III trial by US FDA. As invited speakers,
Dr. Cheng has visited many institutes at foreign countries
and attended at international conferences. |
|
| |
|
